Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$1760b Graphic](https://lunarcrush.com/gi/w:26/t:$1760b.png) $1760b

Eli Lilly (LLY) reported a massive Q3 earnings beat with revenue at $17.60B, significantly exceeding estimates and driving a strong stock performance. The company also raised its full-year guidance, signaling continued positive momentum.

### About $1760b
$1760b is a digital asset with significant social media attention and recent high engagement.  

### Insights [#](/topic/$1760b/insights)
- $1760b creators is up 2700% from the previous X months.
- $1760b mentions is up 3100% from the previous X months.
- $1760b posts created is up 3100% from the previous X months.
- $1760b Creators hit a 52-Week high of XX for the day
- $1760b Creators hit an all time of XX for the day
- $1760b Mentions hit a 52-Week high of XX for the day
- $1760b Mentions hit an all time of XX for the day
- $1760b Engagements hit a 52-Week high of XXXXXX for the day
- $1760b Engagements hit an all time of XXXXXX for the day

### Engagements: XXX [#](/topic/$1760b/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$1760b/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$1760b/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXXXXX +39,273%  
**1 Month**: XXXXXX +1,275%  
**6 Months**: XXXXXX +1,231%  
**1 Year**: XXXXXX +75%  
**1-Year High**: XXXXXX on 2025-10-30  
**1-Year Low**: X on 2024-12-13  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: XX [#](/topic/$1760b/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$1760b/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$1760b/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: X  
**1 Week**: XX +633%  
**1 Month**: XX +225%  
**6 Months**: XX +371%  
**1 Year**: XX +567%  
**1-Year High**: XX on 2025-11-02  
**1-Year Low**: X on 2024-11-08  

| Social Network | X   |
| -------------- | -   |
| Mentions       | XXX |
  

  
  
### Creators: XX [#](/topic/$1760b/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$1760b/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$1760b/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $1760b in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: X  
**1 Week**: XX +1,000%  
**1 Month**: XX +257%  
**6 Months**: XX +867%  
**1 Year**: XX +417%  
**1-Year High**: XX on 2025-11-02  
**1-Year Low**: X on 2024-11-08  
  
  
### Sentiment: XXX% [#](/topic/$1760b/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$1760b/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$1760b/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XXX%  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-09-25  
**1-Year Low**: XXX% on 2025-09-25  

**Most Supportive Themes**
- **Bullish Sentiment:** (60%) Positive sentiment towards the asset's potential.
  
**Most Critical Themes**
- **Market Volatility:** (20%)  Concerns about market fluctuations and potential risks.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %    |
| ------- | -------- | -   | ------- | -   | -------- | -    |
| X       | XX       | XX% | XX      | X%  |          |      |
|         |          |     |         |     |          |      |
| Total   | XX       | X%  | XX      | XX% | X        | NaN% |
  


**Top assets mentioned**
In the posts about $1760b in the last XX hours

[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Eli Lilly and Company (LLY)](/topic/$lly)
[Novo-Nordisk (NVO)](/topic/$nvo)

**Top topics mentioned**
In the posts about $1760b in the last XX hours

[eli lilly](/topic/eli-lilly), [stocks healthcare](/topic/stocks-healthcare), [$lly](/topic/$lly), [$635b](/topic/$635b), [$1607b](/topic/$1607b), [$630b](/topic/$630b), [eps](/topic/eps), [$6163b](/topic/$6163b), [$652b](/topic/$652b), [$558b](/topic/$558b), [$359b](/topic/$359b), [$334b](/topic/$334b), [$549b](/topic/$549b), [$600b](/topic/$600b), [$620b](/topic/$620b), [investment](/topic/investment), [$1605b](/topic/$1605b), [dividend yield](/topic/dividend-yield), [$nvo](/topic/$nvo), [money](/topic/money), [instead of](/topic/instead-of), [$6325b](/topic/$6325b), [outlook](/topic/outlook), [$1602b](/topic/$1602b), [$62b](/topic/$62b), [$60b](/topic/$60b), [$63b](/topic/$63b), [eli](/topic/eli)

### Top Social Posts [#](/topic/$1760b/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Eli Lilly's GLP-1 Gold Rush Eli Lilly smashed Q3 earnings estimates reporting $17.60B in revenue as sales of its weight-loss drug Zepbound surged XXX% and diabetes drug Mounjaro rose XXX% The company significantly raised its full-year revenue guidance to a range of $63B to $63.5B up from a previous forecast of $60B to $62B The results solidify Eli Lilly's dominant market share against rival Novo Nordisk fueled by strong international demand and a direct-to-consumer sales push including a new partnership with Walmart"  
[X Link](https://x.com/NetAxisGroup/status/1984349661637787973) [@NetAxisGroup](/creator/x/NetAxisGroup) 2025-10-31T20:00Z 4921 followers, XXX engagements


"📈 Eli Lilly $LLY is up XXX% after reporting strong sales of its Mounjaro and Zepbound drugs leading to better-than-expected earnings"  
[X Link](https://x.com/VibeInvesting/status/1983952993067089966) [@VibeInvesting](/creator/x/VibeInvesting) 2025-10-30T17:43Z 1472 followers, XX engagements


"🚨 $LLY Eli Lilly and Company earnings results 💥 EPS: $XXXX vs. $XXXX est. (+23.37%) ✅ Revenue: $17.60B vs. $16.05B est. (+9.64%) ✅ #Earnings #StockMarket"  
[X Link](https://x.com/ScpFundamental/status/1983931036640665964) [@ScpFundamental](/creator/x/ScpFundamental) 2025-10-30T16:16Z XXX followers, XX engagements


"$LLY Eli Lilly is +3.6% this morning 🔹 EPS: $XXXX vs. $XXXX est. ✅ 🔹 Revenue: $17.60B vs. $16.05B est. ✅ Key takeaways: 🔸 Mounjaro rev: +109% YoY 🔸 Zepbound rev: +185% YoY 🔸 Verzenio rev: +7% YoY 🔸 FY rev outlook: $63.25B (raised) 🔸 FY EPS outlook: $XXXXX (raised)"  
[X Link](https://x.com/CmgVenture/status/1983875554425127141) [@CmgVenture](/creator/x/CmgVenture) 2025-10-30T12:36Z 11.1K followers, 1185 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$1760b Graphic $1760b

Eli Lilly (LLY) reported a massive Q3 earnings beat with revenue at $17.60B, significantly exceeding estimates and driving a strong stock performance. The company also raised its full-year guidance, signaling continued positive momentum.

About $1760b

$1760b is a digital asset with significant social media attention and recent high engagement.

Insights #

  • $1760b creators is up 2700% from the previous X months.
  • $1760b mentions is up 3100% from the previous X months.
  • $1760b posts created is up 3100% from the previous X months.
  • $1760b Creators hit a 52-Week high of XX for the day
  • $1760b Creators hit an all time of XX for the day
  • $1760b Mentions hit a 52-Week high of XX for the day
  • $1760b Mentions hit an all time of XX for the day
  • $1760b Engagements hit a 52-Week high of XXXXXX for the day
  • $1760b Engagements hit an all time of XXXXXX for the day

Engagements: XXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Week: XXXXXX +39,273%
1 Month: XXXXXX +1,275%
6 Months: XXXXXX +1,231%
1 Year: XXXXXX +75%
1-Year High: XXXXXX on 2025-10-30
1-Year Low: X on 2024-12-13

Social Network X
Engagements XXX

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: X
1 Week: XX +633%
1 Month: XX +225%
6 Months: XX +371%
1 Year: XX +567%
1-Year High: XX on 2025-11-02
1-Year Low: X on 2024-11-08

Social Network X
Mentions XXX

Creators: XX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $1760b in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: X
1 Week: XX +1,000%
1 Month: XX +257%
6 Months: XX +867%
1 Year: XX +417%
1-Year High: XX on 2025-11-02
1-Year Low: X on 2024-11-08

Sentiment: XXX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XXX%
1 Month: XXX% no change
1-Year High: XXX% on 2025-09-25
1-Year Low: XXX% on 2025-09-25

Most Supportive Themes

  • Bullish Sentiment: (60%) Positive sentiment towards the asset's potential.

Most Critical Themes

  • Market Volatility: (20%) Concerns about market fluctuations and potential risks.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XX XX% XX X%
Total XX X% XX XX% X NaN%

Top assets mentioned In the posts about $1760b in the last XX hours

Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) Novo-Nordisk (NVO)

Top topics mentioned In the posts about $1760b in the last XX hours

eli lilly, stocks healthcare, $lly, $635b, $1607b, $630b, eps, $6163b, $652b, $558b, $359b, $334b, $549b, $600b, $620b, investment, $1605b, dividend yield, $nvo, money, instead of, $6325b, outlook, $1602b, $62b, $60b, $63b, eli

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Eli Lilly's GLP-1 Gold Rush Eli Lilly smashed Q3 earnings estimates reporting $17.60B in revenue as sales of its weight-loss drug Zepbound surged XXX% and diabetes drug Mounjaro rose XXX% The company significantly raised its full-year revenue guidance to a range of $63B to $63.5B up from a previous forecast of $60B to $62B The results solidify Eli Lilly's dominant market share against rival Novo Nordisk fueled by strong international demand and a direct-to-consumer sales push including a new partnership with Walmart"
X Link @NetAxisGroup 2025-10-31T20:00Z 4921 followers, XXX engagements

"📈 Eli Lilly $LLY is up XXX% after reporting strong sales of its Mounjaro and Zepbound drugs leading to better-than-expected earnings"
X Link @VibeInvesting 2025-10-30T17:43Z 1472 followers, XX engagements

"🚨 $LLY Eli Lilly and Company earnings results 💥 EPS: $XXXX vs. $XXXX est. (+23.37%) ✅ Revenue: $17.60B vs. $16.05B est. (+9.64%) ✅ #Earnings #StockMarket"
X Link @ScpFundamental 2025-10-30T16:16Z XXX followers, XX engagements

"$LLY Eli Lilly is +3.6% this morning 🔹 EPS: $XXXX vs. $XXXX est. ✅ 🔹 Revenue: $17.60B vs. $16.05B est. ✅ Key takeaways: 🔸 Mounjaro rev: +109% YoY 🔸 Zepbound rev: +185% YoY 🔸 Verzenio rev: +7% YoY 🔸 FY rev outlook: $63.25B (raised) 🔸 FY EPS outlook: $XXXXX (raised)"
X Link @CmgVenture 2025-10-30T12:36Z 11.1K followers, 1185 engagements

$1760b
/topic/$1760b